Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-004-4 | CAS number: 50-03-3
Endpoint summary
Administrative data
Description of key information
Intramuscular (rabbit, non-GLP, dose: 5 mg/kg): LD50 >5 mg/animal
(Schering AG, Report dated 1969-06-04)
Additionally, results of acute toxicity studies with hydrocortisone-21-acetate are cited in RTECS database (Feb 2010):
Subcutaneous, (rat); LDLo: 250 mg/kg
(Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 27, p. 2102, 1977 (ARZNAD))
Intraperitoneal, (mouse); LD50: 2300 mg/kg
(Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*))
Subcutaneous, (mouse); LD50: 45050 ug/kg
(National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*))
Oral, (mouse); LD50: 3267 mg/kg
(Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 42, 2002 (TOVEFN))
Oral, (rat); LD50: 5000 mg/kg
(Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 42, 2002 (TOVEFN))
Dermal, (rat); TDLo: 5 mg/kg
(Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 42, 2002 (TOVEFN))
Inhalation, (rat); TCLo: 0.62 mg/m3/4H
(Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 42, 2002 (TOVEFN))
Key value for chemical safety assessment
Additional information
Single intramuscular application of 5 mg ZK 5192 to 6 male rabbits did not results in any treatment-related findings: LD50 >5 mg/animal [Schering AG, Report dated 1969-06-04]
Additionally, results of acute toxicity studies with hydrocortisone-21-acetate are cited in RTECS database (Feb 2010):
Single subcutaneous application to rats results in LDLo: 250 mg/kg [Arzneimittel-Forschung. Drug Research. [Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- v. 27, p. 2102, 1977 (ARZNAD)]
Single intraperitoneal administration to mice results in LD50: 2300 mg/kg [Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) (CLDND*)]
Acute subcutaneous toxicity study in mice results in LD50: 45050 ug/kg [National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) JAN1986 (NCISP*)]
Single oral application of hydrocortisone-21-acetate leads to somnolence (general depressed activity), reduced food intake and hemorrhage; LD50: 3267 mg/kg [Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 42, 2002 (TOVEFN)]
Oral application to rats results in somnolence (general depressed activity), changes in liver and spleen, adrenal cortex hyperplasia, hemorrhage, reduced food intake and other vascular changes; LD50: 5000 mg/kg [Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 42, 2002 (TOVEFN)]
Dermal application of hydrocortisone-21-acetate to rats leads to somnolence (general depressed activity), changes in heart, spleen and thyroid weight and other changes in liver; TDLo: 5 mg/kg [Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 42, 2002 (TOVEFN)]
Inhalation application of hydrocortisone-21-acetate to rats over 4 h results in changes in liver, decrease of urine volume and changes in serum composition (e.g. totasl protein, billirubin and cholesterol); TCLo: 0.62 mg/m3/4H [Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown v. (2), p. 42, 2002 (TOVEFN)]
Justification for classification or non-classification
Since LD50 (oral) is above 2000 mg/kg classification is not required according to 67/548/EEC and Regulation (EC) 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
